BLCM - Bellicum Pharmaceuticals Stock Trading

Bellicum Pharmaceuticals Inc.(NASDAQ: BLCM) stock trading, description, contact, officers and directors.

About Bellicum Pharmaceuticals Inc.

Not available

Stock Information

Bellicum Pharmaceuticals Inc. Company Name:

BLCM Stock Symbol:

NASDAQ Market:

BLCM - Bellicum Pharmaceuticals Stock Trading

Get BLCM Alerts

News, Short Squeeze, Breakout and More Instantly...

BLCM - Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update

Enrolled first patient in Phase 1/2 clinical trial for BPX-603 in solid tumors that express HER2 Clinical hold lifted on Phase 1/2 dose-escalation trial evaluating BPX-601 and rimiducid in patients with previously treated metastatic prostate or pancreatic cancer Conferen...
BLCM - Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

HOUSTON, March 23, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it will report financial results for the fourth quarter and full year 2020 after the close of U.S. marke...
BLCM - Bellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity

HOUSTON, March 04, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the publication of a case report using the company’s CaspaCIDe (inducible caspase-9, or iC9) safe...